Search research articles
Contact Us
Filters
Showing results (81-90 of 142) with videos related to
Page
of 15
Sort By:
Advances in Therapy
|
April 28, 2025
Correction to: Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature Review
Piotr Wiland, Charlotte Both, Norman B Gaylis, et al.
Intestinal Research
|
February 7, 2022
Vedolizumab for perianal fistulizing Crohn's disease: systematic review and meta-analysis
Fares Ayoub, Matthew Odenwald, Dejan Micic, et al.
Journal of Clinical Medicine
|
March 17, 2025
Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease
Gionata Fiorino, Ashwin Ananthakrishnan, Russell D Cohen, et al.
Gastroenterology
|
September 14, 2004
Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial
Stephen B Hanauer, Burton I Korelitz, Paul Rutgeerts, et al.
Journal of Crohn'S & Colitis
|
February 28, 2019
Low-Dose Metronidazole is Associated With a Decreased Rate of Endoscopic Recurrence of Crohn's Disease After Ileal Resection: A Retrospective Cohort Study
Laura R Glick, Philip H Sossenheimer, Jacob E Ollech, et al.
Inflammatory Bowel Diseases
|
December 15, 2015
Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia
Noa Krugliak Cleveland, Ruben J Colman, Dylan Rodriquez, et al.
The American Journal of Gastroenterology
|
January 8, 2014
Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Registry
Gary R Lichtenstein, Brian G Feagan, Russell D Cohen, et al.
Inflammatory Bowel Diseases
|
February 21, 2018
Infliximab for Crohn's Disease: More Than 13 Years of Real-world Experience
Gary R Lichtenstein, Brian G Feagan, Russell D Cohen, et al.
Inflammatory Bowel Diseases
|
December 15, 2020
Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis
Sujaata Dwadasi, Maryam Zafer, Donald Goens, et al.
Journal of Crohn'S & Colitis
|
February 7, 2019
Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe
Roni Weisshof, Jacob E Ollech, Katia El Jurdi, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 142) with videos related to
Sort By:
Page
of 15
Advances in Therapy
|
April 28, 2025
Correction to: Efficacy, Safety, and Immunogenicity of SDZ-ADL, an Adalimumab Biosimilar, in Biologic-Naïve and Switched Patients with Immune-Mediated Inflammatory Diseases: A Literature Review
Piotr Wiland, Charlotte Both, Norman B Gaylis, et al.
Intestinal Research
|
February 7, 2022
Vedolizumab for perianal fistulizing Crohn's disease: systematic review and meta-analysis
Fares Ayoub, Matthew Odenwald, Dejan Micic, et al.
Journal of Clinical Medicine
|
March 17, 2025
Accelerating Earlier Access to Anti-TNF-α Agents with Biosimilar Medicines in the Management of Inflammatory Bowel Disease
Gionata Fiorino, Ashwin Ananthakrishnan, Russell D Cohen, et al.
Gastroenterology
|
September 14, 2004
Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: a 2-year trial
Stephen B Hanauer, Burton I Korelitz, Paul Rutgeerts, et al.
Journal of Crohn'S & Colitis
|
February 28, 2019
Low-Dose Metronidazole is Associated With a Decreased Rate of Endoscopic Recurrence of Crohn's Disease After Ileal Resection: A Retrospective Cohort Study
Laura R Glick, Philip H Sossenheimer, Jacob E Ollech, et al.
Inflammatory Bowel Diseases
|
December 15, 2015
Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia
Noa Krugliak Cleveland, Ruben J Colman, Dylan Rodriquez, et al.
The American Journal of Gastroenterology
|
January 8, 2014
Drug therapies and the risk of malignancy in Crohn's disease: results from the TREAT™ Registry
Gary R Lichtenstein, Brian G Feagan, Russell D Cohen, et al.
Inflammatory Bowel Diseases
|
February 21, 2018
Infliximab for Crohn's Disease: More Than 13 Years of Real-world Experience
Gary R Lichtenstein, Brian G Feagan, Russell D Cohen, et al.
Inflammatory Bowel Diseases
|
December 15, 2020
Inpatient Therapy With Calcineurin Inhibitors in Severe Ulcerative Colitis
Sujaata Dwadasi, Maryam Zafer, Donald Goens, et al.
Journal of Crohn'S & Colitis
|
February 7, 2019
Ciclosporin Therapy After Infliximab Failure in Hospitalized Patients With Acute Severe Colitis is Effective and Safe
Roni Weisshof, Jacob E Ollech, Katia El Jurdi, et al.
Page
of 15